Aura Biosciences to Present Phase 1b/2 Clinical Data for AU-011 at the American Academy of Ophthalmology 2018 Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences today announced that it will be highlighting its Phase 1b/2 clinical data for AU-011 at the AAO 2018 Annual Meeting.